CME Group’s Q2 earnings report looms as a pivotal moment — analysts expect flat revenue after double-digit growth last year, following recent misses despite rising top-line numbers. While peers like FactSet and Goldman Sachs soared with strong beats, CME’s stock has lagged, trading below its $280 average target. Can they reverse course and ignite investor momentum in a sector otherwise on fire?

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/62833267e05d28ca

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av, eller tillsammans med, Poddtoppen.